{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:23:56Z","timestamp":1793899436386,"version":"4.8.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Doxorubicin (DOX), an anthracycline type of chemotherapy, is an effective therapy for several types of cancer, but serious side effects, such as severe hepatotoxicity, limit its use currently. Accordingly, an effective therapeutic strategy to prevent DOX-related hepatotoxicity is urgently needed. Through the inhibition of oxidative stress, fibroblast growth factor 1 (FGF1) is an effect therapy for a variety of liver diseases, but its use is limited by an increased risk of tumorigenesis due to hyperproliferation. Resveratrol (RES), a natural product, inhibits the growth of many cancer cell lines, including liver, breast, and prostate cancer cells. Therefore, this study explored whether and how RES in combination with FGF1 can alleviate DOX-induced hepatotoxicity. The results showed that RES or FGF1 alone improved DOX-induced hepatic inflammation, apoptosis and oxidative stress, and these adverse effects were further attenuated after treatment with both RES and FGF1. Mechanistically, both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> results showed that RES\/FGF1 reduced oxidative stress and thereby alleviated liver injury by promoting nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2) and subsequently upregulating expression of antioxidant proteins in an adenosine monophosphate-activated protein kinase (AMPK)-dependent manner. Together, our results not only demonstrate that co-treatment with RES and FGF1 significantly inhibited DOX-induced hepatic inflammation and apoptosis, but also that co-treatment with RES and FGF1 markedly suppressed DOX-induced hepatic oxidative stress, <jats:italic>via<\/jats:italic> targeting the AMPK\/NRF2 pathway and subsequently ameliorating hepatic dysfunction. Thus, the combination of RES and FGF1 may provide a new therapeutic strategy for limiting DOX-induced hepatotoxicity.<\/jats:p>","DOI":"10.3389\/fphar.2022.940406","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T06:25:35Z","timestamp":1661840735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK\/NRF2 Pathway"],"prefix":"10.3389","volume":"13","author":[{"given":"Xianchou","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peinan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/antiox10121998","article-title":"Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study","volume":"10","author":"Alasmari","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/nu13010041","article-title":"Creatine Alleviates Doxorubicin-Induced Liver Damage by Inhibiting Liver Fibrosis, Inflammation, Oxidative Stress, and Cellular Senescence","volume":"13","author":"Aljobaily","year":"2020","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrc.2017.8","article-title":"Advances and Challenges in Targeting FGFR Signalling in Cancer","volume":"17","author":"Babina","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8296451","DOI":"10.1155\/2018\/8296451","article-title":"Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2\/HO-1 Defense Pathway","volume":"2018","author":"Barakat","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5180242","DOI":"10.1155\/2022\/5180242","article-title":"4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes","volume":"2022","author":"Chu","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2079","DOI":"10.1038\/cddis.2016.2","article-title":"FGF1 C-Terminal Domain and Phosphorylation Regulate Intracrine FGF1 Signaling for its Neurotrophic and Anti-apoptotic Activities","volume":"7","author":"Delmas","year":"2016","journal-title":"Cell Death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9734560","DOI":"10.1155\/2020\/9734560","article-title":"Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK\/Nrf2\/NF\u03baB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice","volume":"2020","author":"Ding","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1017\/S0007114515002433","article-title":"The Effects of Resveratrol Supplementation on Cardiovascular Risk Factors in Patients with Non-Alcoholic Fatty Liver Disease: A Randomised, Double-Blind, Placebo-Controlled Study","volume":"114","author":"Faghihzadeh","year":"2015","journal-title":"Br. J. Nutr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/nu10070855","article-title":"Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.celrep.2018.12.036","article-title":"Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD","volume":"26","author":"Garcia","year":"2019","journal-title":"Cell Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrendo.2017.78","article-title":"FGF1 - A New Weapon to Control Type 2 Diabetes Mellitus","volume":"13","author":"Gasser","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"117212","DOI":"10.1016\/j.lfs.2019.117212","article-title":"Resveratrol Ameliorates Metabolic Disorders and Insulin Resistance in High-Fat Diet-Fed Mice","volume":"242","author":"Gong","year":"2020","journal-title":"Life Sci."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041279","article-title":"Sexual Dimorphism in Doxorubicin-Induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation","volume":"21","author":"Grant","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"105667","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol Alleviates Non-Alcoholic Fatty Liver Disease through Epigenetic Modification of the Nrf2 Signaling Pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/nu13030933","article-title":"The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbagen.2013.10.023","article-title":"Resveratrol Enhances Chemosensitivity of Doxorubicin in Multidrug-Resistant Human Breast Cancer Cells via Increased Cellular Influx of Doxorubicin","volume":"1840","author":"Kim","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms18122589","article-title":"The Role of Resveratrol in Cancer Therapy","volume":"18","author":"Ko","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"724514","DOI":"10.3389\/fphar.2021.724514","article-title":"AICAR, an AMP-Activated Protein Kinase Activator, Ameliorates Acute Pancreatitis-Associated Liver Injury Partially through Nrf2-Mediated Antioxidant Effects and Inhibition of NLRP3 Inflammasome Activation","volume":"12","author":"Kong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1016\/j.jmb.2018.08.004","article-title":"Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation","volume":"430","author":"Kostas","year":"2018","journal-title":"J. Mol. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"108889","DOI":"10.1016\/j.cbi.2019.108889","article-title":"Rifampicin Activates AMPK and Alleviates Oxidative Stress in the Liver as Mediated with Nrf2 Signaling","volume":"315","author":"Lee","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/hep.31568","article-title":"Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection from Nonalcoholic Fatty Liver Disease in Mice","volume":"73","author":"Lin","year":"2021","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1021\/acs.jafc.9b07860","article-title":"Occurrence, Bioavailability, Anti-Inflammatory, and Anticancer Effects of Pterostilbene","volume":"68","author":"Lin","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3892\/mmr.2015.4665","article-title":"Resveratrol Protects Cardiomyocytes from Doxorubicin-Induced Apoptosis through the AMPK\/P53 Pathway","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12964-018-0314-2","article-title":"Corilagin Alleviates Acetaminophen-Induced Hepatotoxicity via Enhancing the AMPK\/GSK3\u03b2-Nrf2 Signaling Pathway","volume":"17","author":"Lv","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1039\/c9fo02429h","article-title":"Astaxanthin from Haematococcus pluvialis Ameliorates the Chemotherapeutic Drug (Doxorubicin) Induced Liver Injury through the Keap1\/Nrf2\/HO-1 Pathway in Mice","volume":"11","author":"Ma","year":"2020","journal-title":"Food Funct."},{"key":"B26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/antiox10030343","article-title":"Consideration of Sex as a Biological Variable in the Development of Doxorubicin Myotoxicity and the Efficacy of Exercise as a Therapeutic Intervention","volume":"10","author":"Montalvo","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/nu12010161","article-title":"Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial","volume":"12","author":"Movahed","year":"2020","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.fct.2015.02.009","article-title":"Theanine Prevents Doxorubicin-Induced Acute Hepatotoxicity by Reducing Intrinsic Apoptotic Response","volume":"78","author":"Nagai","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK\/Nrf2 Pathway","volume":"30","author":"Qu","year":"2016","journal-title":"Phytother. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ajt.12954","article-title":"ATF3-Mediated NRF2\/HO-1 Signaling Regulates TLR4 Innate Immune Responses in Mouse Liver Ischemia\/Reperfusion Injury","volume":"15","author":"Rao","year":"2015","journal-title":"Am. J. Transpl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphar.2019.01030","article-title":"Protective Effects of Dioscin against Doxorubicin-Induced Hepatotoxicity via Regulation of Sirt1\/FOXO1\/NF-\u039ab Signal","volume":"10","author":"Song","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41589-019-0304-8","article-title":"Harnessing the Anti-Cancer Natural Product Nimbolide for Targeted Protein Degradation","volume":"15","author":"Spradlin","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101811","DOI":"10.1016\/j.redox.2020.101811","article-title":"AFGF Alleviates Diabetic Endothelial Dysfunction by Decreasing Oxidative Stress via Wnt\/\u03b2-Catenin-Mediated Upregulation of HXK2","volume":"39","author":"Sun","year":"2021","journal-title":"Redox Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an Update on Anticancer Molecular Action, Toxicity and Novel Drug Delivery Systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00204-020-02940-x","article-title":"Hepatotoxicity Induced by Nanomaterials: Mechanisms and In Vitro Models","volume":"95","author":"Vilas-Boas","year":"2021","journal-title":"Arch. Toxicol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-019-1696-9","article-title":"FGF1\u0394HBS Ameliorates Chronic Kidney Disease via PI3K\/AKT Mediated Suppression of Oxidative Stress and Inflammation","volume":"10","author":"Wang","year":"","journal-title":"Cell Death Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-021-00542-2","article-title":"FGF1\u0394HBS Prevents Diabetic Cardiomyopathy by Maintaining Mitochondrial Homeostasis and Reducing Oxidative Stress via AMPK\/Nur77 Suppression","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.clinre.2019.03.006","article-title":"FGF1 Protects against APAP-Induced Hepatotoxicity via Suppression of Oxidative and Endoplasmic Reticulum Stress","volume":"43","author":"Wang","year":"","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.1111\/jcmm.15859","article-title":"Doxorubicin Cardiomyopathy Is Ameliorated by Acacetin via Sirt1-Mediated Activation of AMPK\/Nrf2 Signal Molecules","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/bph.13492","article-title":"Antioxidant Effects of Resveratrol in the Cardiovascular System","volume":"174","author":"Xia","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fphar.2020.00052","article-title":"Fibroblast Growth Factor 1 Ameliorates Diabetes-Induced Liver Injury by Reducing Cellular Stress and Restoring Autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3892\/or.2018.6648","article-title":"Resveratrol Inhibited the Progression of Human Hepatocellular Carcinoma by Inducing Autophagy via Regulating P53 and the Phosphoinositide 3\u2011Kinase\/Protein kinase\u00a0B Pathway","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fphar.2020.00588","article-title":"Matrine: A Promising Natural Product with Various Pharmacological Activities","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/oby.22348","article-title":"Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"27","author":"Zhao","year":"","journal-title":"Obes. (Silver Spring)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"104276","DOI":"10.1016\/j.phrs.2019.104276","article-title":"MicroRNA-128-3p Aggravates Doxorubicin-Induced Liver Injury by Promoting Oxidative Stress via Targeting Sirtuin-1","volume":"146","author":"Zhao","year":"","journal-title":"Pharmacol. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.940406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T06:25:39Z","timestamp":1661840739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.940406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":45,"alternative-id":["10.3389\/fphar.2022.940406"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.940406","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"article-number":"940406"}}